Aarkstore - Ulcerative Colitis - Pipeline Review, H2 2014

1
Ulcerative Colitis - Pipeline Review, H2 2014
Pharmaceutical and Healthcare Market Research
Report
2
Summary

• Ulcerative Colitis - Pipeline Review, H2 2014,
  provides an overview of the Ulcerative Colitiss
  therapeutic pipeline.
• This report provides comprehensive information
  on the therapeutic development for Ulcerative
  Colitis, complete with comparative analysis at
  various stages, therapeutics assessment by drug
  target, mechanism of action (MoA), route of
  administration (RoA) and molecule type, along
  with latest updates, and featured news and press
  releases. It also reviews key players involved in
  the therapeutic development for Ulcerative
  Colitis and special features on late-stage and
  discontinued projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

3
Scope

• The report provides a snapshot of the global
  therapeutic landscape of Ulcerative ColitisThe
  report reviews key pipeline products under drug
  profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activitiesThe report reviews key players
  involved in the therapeutics development for
  Ulcerative Colitis and enlists all their major
  and minor projectsThe report summarizes all the
  dormant and discontinued pipeline projectsA
  review of the Ulcerative Colitis products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sourcesPipeline
  products coverage based on various stages of
  development ranging from pre-registration till
  discovery and undisclosed stages

Browse full report or Sample Request
_at_ http//www.aarkstore.com/pharmaceuticals-healthc
are/60599/type-2-diabetes-pipeline-review-h2-2014
4
Reasons to buy

• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategiesIdentify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantageDevelop strategic
  initiatives by understanding the focus areas of
  leading companiesIdentify and understand
  important and diverse types of therapeutics under
  development for Ulcerative ColitisPlan mergers
  and acquisitions effectively by identifying key
  players of the most promising pipelineDevise
  corrective measures for pipeline projects by
  understanding Ulcerative Colitis pipeline depth
  and focus of Indication therapeuticsDevelop and
  design in-licensing and out-licensing strategies
  by identifying prospective partners with the most
  attractive projects to enhance and expand
  business potential and ScopeModify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline

5
Table of Content

• IntroductionGlobal Markets Direct Report
  CoverageUlcerative Colitis OverviewTherapeutics
  DevelopmentPipeline Products for Ulcerative
  Colitis - OverviewPipeline Products for
  Ulcerative Colitis - Comparative
  AnalysisUlcerative Colitis - Therapeutics under
  Development by CompaniesUlcerative Colitis -
  Therapeutics under Investigation by
  Universities/InstitutesUlcerative Colitis -
  Pipeline Products GlanceLate Stage
  ProductsClinical Stage ProductsEarly Stage
  ProductsUnknown Stage ProductsUlcerative
  Colitis - Products under Development by
  CompaniesUlcerative Colitis - Products under
  Investigation by Universities/InstitutesUlcerativ
  e Colitis - Companies Involved in Therapeutics
  DevelopmentAjinomoto Pharmaceuticals Co., Ltd.

6
List of Tables

• Number of Products under Development for
  Ulcerative Colitis, H2 2014Number of Products
  under Development for Ulcerative Colitis -
  Comparative Analysis, H2 2014Number of Products
  under Development by Companies, H2 2014Number of
  Products under Development by Companies, H2 2014
  (Contd..1)Number of Products under Development
  by Companies, H2 2014 (Contd..2)Number of
  Products under Development by Companies, H2 2014
  (Contd..3)Number of Products under Development
  by Companies, H2 2014 (Contd..4)Number of
  Products under Investigation by
  Universities/Institutes, H2 2014Comparative
  Analysis by Late Stage Development, H2
  2014Comparative Analysis by Clinical Stage
  Development, H2 2014Comparative Analysis by
  Early Stage Development, H2 2014Comparative
  Analysis by Unknown Stage Development, H2
  2014Products under Development by Companies, H2
  2014Products under Development by Companies, H2
  2014 (Contd..1)Products under Development by
  Companies, H2 2014 (Contd..2)Products under
  Development by Companies, H2 2014 (Contd..3)

7
List of Figures

• Number of Products under Development for
  Ulcerative Colitis, H2 2014Number of Products
  under Development for Ulcerative Colitis -
  Comparative Analysis, H2 2014Number of Products
  under Development by Companies, H2 2014Number of
  Products under Investigation by
  Universities/Institutes, H2 2014Comparative
  Analysis by Late Stage Development, H2
  2014Comparative Analysis by Clinical Stage
  Development, H2 2014Comparative Analysis by
  Early Stage Products, H2 2014Comparative
  Analysis by Unknown Stage Development, H2
  2014Assessment by Monotherapy Products, H2
  2014Assessment by Combination Products, H2
  2014Number of Products by Top 10 Targets, H2
  2014Number of Products by Stage and Top 10
  Targets, H2 2014Number of Products by Top 10
  Mechanism of Actions, H2 2014

8
Related Reports

• Sinusitis-Pipeline Insights, 2015
• Oligodendroglioma-Pipeline Insights, 2015
• Familial Hypercholesterolemia (Type II
  Hyperlipoproteinemia)-Pipeline Insights, 2015
• Fatty Liver Disease-Pipeline Insights, 2015
• Skin And Skin Structure Infections by
  S.Pneumoniae-Pipeline Insights, 2015
• Opioid-Induced Constipation (OIC)-Pipeline
  Insights, 2015
• Female Infertility-Pipeline Insights, 2015
• Optic Neuritis-Pipeline Insights, 2015

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953